Visiting scientist: Dr Smita Joshi13/09/2021Dr Smita Joshi, Senior Scientist in Pune, India, has been awarded a UICC Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants to complete the data analysis and manuscript based on the 10 years follow-up of a large cohort of women living with HIV. Dr Joshi will also help us to develop the comprehensive learning package on cervical cancer screening for the WHO Knowledge Academy. |
New publication: The Porto European Cancer Research Summit 202113/09/2021IARC scientists and key stakeholders from the cancer research continuum participated at the European Cancer Research Summit in Porto to discuss priorities and specific action points required for the successful implementation of the European Cancer Mission and Europe's Beating Cancer Plan (EBCP). View the report |
Cervical cancer elimination initiative - Knowledge Repository10/09/2021WHO launched a publicly accessible web-based platform, the knowledge repository, intended to provide one-stop access to documents and tools relevant to support the implementation of the Global strategy to accelerate the elimination of cervical cancer as a public health problem. The repository brings together knowledge elements developed by WHO, UN Agencies and other intergovernmental organizations, or by their collaborative efforts with other partners.
View the platform |
New release (August) of the CanScreen5 platform with new country data31/08/2021The CanScreen5 IARC Secretariat, following support of country collaborators and validation by our scientific committee, is happy to announce the availability on the CanScreen5 platform of the following country factsheets: Bostwana, Canada (New Brunswick, and Newfoundland and Labrador provinces data), Japan, Libya, Mozambique, Namibia, and Thailand.
Visit the CanScreen5 website to explore characteristics and performance of cancer screening programmes across the globe in more than 54 countries |
New release (July) of the CanScreen5 platform with new country data31/07/2021The CanScreen5 IARC Secretariat, following support of country collaborators and validation by our scientific committee, is happy to announce the availability on the CanScreen5 platform of the following country factsheets: Cabo Verde, Côte d'Ivoire, Dominica, Ethiopia, Grenada, Republic of Korea, Rwanda, and Sri Lanka.
Visit the CanScreen5 website to explore characteristics and performance of cancer screening programmes across the globe in more than 48 countries |
New publication: Patterns of care of breast cancer patients in Morocco – A study of variations in patient profile, tumour characteristics and standard of care over a decade13/07/2021A new article by scientists from the International Agency for Research on Cancer (IARC) and clinicians from Morocco describes the pattern of care of breast cancer patients within the two main oncology centres in Morocco. This retrospective study included more than 2000 patients treated between 2008 and 2017. The article reports that the standard of breast cancer treatment and survival outcome at the oncology centre in Rabat were comparable to that observed in many high-resourced countries. However, the disparity between the two oncology centres also revealed inequality that exists within the country. View the article |
New publication: WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition06/07/2021This new WHO guideline, launched today, is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical pre-cancer lesions for cervical cancer. It includes some important shifts in WHO’s recommended approaches to cervical screening, and includes a total of 23 recommendations and 7 good practice statements. View the publication |
Webinar: Reaching 2030 cervical cancer elimination targets - New WHO recommendations for screening and treatment of cervical pre-cancer05/07/2021To launch updated guidance, WHO and the International Agency for Research on Cancer (IARC) will host a webinar to detail new recommendations on screening and treatment for cervical pre-cancer, best practices and implications for national programmes. The guidelines include recommendations for the general population as well as for women living with HIV/AIDS. Webinar sessions will be 06/07/2021 at 9h00 to 10h30 CET (Geneva time) or 14h30 to 16h00 CET (Geneva time). View more details about this event on the WHO page |
New publication: The use of thermal ablation in diverse cervical cancer 'screen-and-treat' service platforms in Zambia01/07/2021In this publication, the authors reported the feasibility, acceptability, safety and provider uptake of thermal ablation in diverse Zambian clinical contexts. Between 2012 to 2020, 2,123 women were treated by thermal ablation in primary healthcare clinics, mobile outreach clinics and research clinics. It was the preferred ablative method of providers when compared to cryotherapy and feasible, safe, and acceptable. View the article |
New release (June) of the CanScreen5 platform with new country data30/06/2021The CanScreen5 IARC Secretariat, following support of country collaborators and validation by our scientific committee, is happy to announce the availability on the CanScreen5 platform of the following country factsheets: Bangladesh, Canada (Alberta, Ontario, and Saskatchewan provinces data), El Salvator, Kenya, Honduras, India (Assam State data), Nicaragua, Norway, Paraguay, Spain (Basque region data), Turkey, United Republic of Tanzania, and Zimbabwe.
Visit the CanScreen5 website to explore characteristics and performance of cancer screening programmes across the globe in more than 40 countries |